In my personal view 2026 will be a defining point for #AVCT and ultimately for long term cancer patients.
Thanks to all shareholders and stakeholders for their support.
On the train back to the West Country after the Avacta Science Day and a glorious number of pints.
Absolutely mind blowing what #AVCT $AVCT has already achieved. It has built a delivery platform for all anti-cancer warheads that could make the antibody-drug conjugate class, essentially obsolete, in a few short years - for pretty much 85-90% of all cancer cases worldwide.
The UK investment community appears to be maxed out in buying the stock. In reality, we need US and other international punters to set eyes on the stock for the first time and realise what an absolute diamond the pre|CISION platform is.
In the bull-case (which appears eminently achievable after today), that platform becomes the omnipresent delivery platform for all small molecule and biologics drugs treating solid tumours.
Thatโs almost 90% of the global oncology market. In 5 years, thatโll be >$500bn pa.
Wake up, ex-UK punters!
@Cumulus51896691@RAH00084 This is exactly what Iโve been feeling. A quiet internal thought to myself each and every day for the last 5 years. Each month Iโve faithfully added to my stack, some months Iโve had tremors of worry at 35p but Iโve kept adding and keeping the faith. Time to ring the bell ๐
@MylesMcNulty Absolutely full prayers and best wishes to the brave patients on this trial. May they benefit greatly from our groundbreaking tech ๐๐ป
@55_retire Gotta start with a 5 minimumโฆ. ยฃ50b will suffice - whole platformโฆ revolutionise Cancer treatmentโฆ unlimited profits and cancer sufferers everywhere given hope without compromise!
@DrJN_SportsMed Wishing you a rapid and full recovery James. Weโve all seen patients like this and IT CAN turn around. Timescales maybe stretched but be patient, you will prevail ๐ช๐ผโญ๏ธ